Drug
TS-172
TS-172 is a pharmaceutical drug with 6 clinical trials. Currently 2 active trials ongoing. Historical success rate of 100.0%.
Total Trials
6
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 4 completed trials
Completion Rate
100%(4/4)
Active Trials
2(33%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_1
4
67%
Ph phase_3
1
17%
Ph phase_2
1
17%
Phase Distribution
4
Early Stage
1
Mid Stage
1
Late Stage
Phase Distribution6 total trials
Phase 1Safety & dosage
4(66.7%)
Phase 2Efficacy & side effects
1(16.7%)
Phase 3Large-scale testing
1(16.7%)
Highest Phase Reached
Phase 3Trial Status & Enrollment
Completion Rate
100.0%
4 of 4 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
2
trials recruiting
Total Trials
6
all time
Status Distribution
Active(2)
Completed(4)
Detailed Status
Completed4
Recruiting2
Development Timeline
Analytics
Development Status
Total Trials
6
Active
2
Success Rate
100.0%
Most Advanced
Phase 3
Trials by Phase
Phase 14 (66.7%)
Phase 21 (16.7%)
Phase 31 (16.7%)
Trials by Status
completed467%
recruiting233%
Recent Activity
2 active trials
Showing 5 of 6
recruitingphase_1
A Pharmacokinetic Study of TS-172 in Patients With Hepatic Impairment
NCT07231029
recruitingphase_3
A Long-term Study of TS-172 in Hyperphosphatemia Patients on Hemodialysis
NCT07285304
completedphase_1
A Pharmacodynamic Study of TS-172 in Healthy Adult Male Subjects
NCT07084961
completedphase_2
A Phase 2 Study of TS-172 in Hyperphosphatemia Patients on Hemodialysis With Phosphate Binders
NCT06745518
completedphase_1
An Open-label Pharmacokinetic Study of TS-172 in Patients on Hemodialysis
NCT06849778
Clinical Trials (6)
Showing 6 of 6 trials
NCT07231029Phase 1
A Pharmacokinetic Study of TS-172 in Patients With Hepatic Impairment
NCT07285304Phase 3
A Long-term Study of TS-172 in Hyperphosphatemia Patients on Hemodialysis
NCT07084961Phase 1
A Pharmacodynamic Study of TS-172 in Healthy Adult Male Subjects
NCT06745518Phase 2
A Phase 2 Study of TS-172 in Hyperphosphatemia Patients on Hemodialysis With Phosphate Binders
NCT06849778Phase 1
An Open-label Pharmacokinetic Study of TS-172 in Patients on Hemodialysis
NCT04979572Phase 1
A Phase I Study of TS-172 in Healthy Adult Subjects (Single and Multiple Doses)
All 6 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 6